UTERINE SEROUS CARCINOMA (USC)
Clinical trials for UTERINE SEROUS CARCINOMA (USC) explained in plain language.
Never miss a new study
Get alerted when new UTERINE SEROUS CARCINOMA (USC) trials appear
Sign up with your email to follow new studies for UTERINE SEROUS CARCINOMA (USC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug SIM0505 enters first human tests for advanced cancers
Disease control Recruiting nowThis early-stage trial is testing an experimental drug called SIM0505 in adults with advanced solid tumors that have not responded to standard treatments. The study aims to find a safe dose and check for any early signs that the drug shrinks tumors. About 414 participants will re…
Matched conditions: UTERINE SEROUS CARCINOMA (USC)
Phase: PHASE1 • Sponsor: NextCure, Inc. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New drug trial targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called BMS-986463 in people with advanced ovarian, uterine, or lung cancer that has spread or cannot be removed by surgery. The main goals are to check safety and find the best dose. About 240 participants will receive the drug, and researc…
Matched conditions: UTERINE SEROUS CARCINOMA (USC)
Phase: PHASE1 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC